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Abstract
Human bone marrow stromal cells regulate the growth of marrow hematopoietic progenitors by secreting cytokines.
 .  .  .Arachidonic acid AA is the fatty acid precursor of prostaglandin E PGE and leukotriene B LTB that modulate the2 2 4 4
growth of human bone marrow progenitors. We have investigated the incorporation of AA in human bone marrow stromal
cell cultures, their production of PGE and LTB and the effect of AA on their growth. Gas chromatography analysis2 4
reveals the presence of AA in the human bone marrow plasma and in bone marrow stromal cell cultures. In stromal cells,
w3 xH -AA is incorporated into triglycerides and is later delivered into phospholipids. Prelabeling-chase experiments indicate a
preferential incorporation of AA into phosphatidylethanolamine and no trafficking of labeled AA between phospholipid
 .  .species. Bone marrow stromal cells release PGE and LTB in response to phorbol myristic acetate PMA 1 mM and2 4
 .  .  .tumor necrosis factor alpha TNF-a 10 ngrml . Exogenous AA up to 1 mM has no significant effect on cell growth. In
conclusion, human bone marrow stromal cells capt exogenous AA and, thus, may participate to the control of marrow AA
concentrations. They may also regulate human marrow hematopoiesis by secreting AA metabolites such as PGE and2
LTB . q 1998 Elsevier Science B.V.4
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1. Introduction
 .Arachidonic acid AA is a 20-carbon polyunsatu-
rated fatty acid which is released after stimulation
from membrane phospholipids and which can be
converted to prostaglandins through the cyclooxy-
genase pathway or to hydroxyeicosatetraenoic acid
 .HETE and to leukotrienes through the lipoxygenase
w xpathway 1 . AA metabolites such as prostaglandin
 .  .E PGE and leukotriene B LTB modulate hu-2 2 4 4
man hematopoiesis by acting on the growth of human
bone marrow erythroid and myeloid progenitors in
) Corresponding author. Fax: q33-05-55-43-58-66 and q33-
05-55-43-58-01.
w xvitro 2–5 . Normal hematopoiesis which is located
in the bone marrow is a dynamic and interactive
process between hematopoietic cells and stromal cells
 .mostly fibroblast-like cells . Marrow stromal cells
are crucial for the long-term survival, proliferation
and differentiation processes of hematopoietic stem
cells and progenitors. They regulate hematopoiesis by
 .interacting directly cell-to-cell contact with hemato-
poietic cells andror by secreting regulatory molecules
 .such as cytokines and growth factors that modulate
w xhematopoiesis 6 .
The presence and the role of AA in the human
marrow is poorly documented. In this study we have
investigated AA in human bone marrow plasma and
marrow stromal cell cultures. We have assessed the
0167-4889r98r$19.00 q 1998 Elsevier Science B.V. All rights reserved.
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uptake, the distribution and the trafficking of AA
among triglycerides and phospholipids in human bone
marrow stomal cells and the effects of AA on their
growth. We also investigated their capacity to release
PGE , 6-keto-PGF and LTB in response to phor-2 1a 4
 .  .bol myristic acetate PMA , interleukin-6 IL-6 and
 .tumor necrosis factor alpha TNF-a .
2. Material and methods
2.1. Bone marrow stromal cell cultures
Cultures of human bone marrow stromal cells were
established from bone marrow aspirates harvested
into heparinized tubes Vacutainer system, Becton
.Dickinson, Meylan, France and considered as nor-
mal by morphological analysis of the May Grunwald
Giemsa stained smears. The procedure was per-
formed on patients undergoing a myelogram as part
of routine procedure. Mononuclear cells were isolated
 .by separation on a Ficoll gradient 400=g, 20 min ,
 .washed two times with HBSS 400=g, 10 min , and
seeded in 75 cm2 culture flasks in RPMI 1640 sup-
 .plemented with 20% fetal calf serum FCS , peni-
 .  .cillin 100 Urml and streptomycin 100 mgrml at
w x378C in 5% CO in air 7 . After one week, nonad-2
herent cells were removed from culture flasks. Ad-
herent cells were grown to confluence for 3 to 5
weeks with weekly changes of medium and were
subcultured after trypsin treatment 0.05% trypsin for
.5 min . The cells used in these experiments were at
w xthe first passage. As previously reported 8 , more
than 99.8% of cells were CD2y and CD22y indicat-
ing the absence of T- and B-cells on the layers and
4% of cells were CD14q and CD33q indicating a
monocytic lineage.
2.2. Fatty acid analysis
Bone marrow plasma was obtained by centrifuga-
 .tion 400=g, 15 min of marrow samples collected
by aspiration into heparinized tubes. Bone marrow
plasma lipids were then extracted according to Floch
w x  6.et al. 9 . Marrow stromal cells 1=10 were plated
into 75 cm2 culture flask with RPMI 1640 with 20%
 .FCS with or without exogenous AA 1 mM . After 5
days of growth, supernatants were removed and ad-
herent cells were washed with HBSS. Cells were
scraped using a rubber policeman, and lipids were
w xextracted 9 . Fatty acids from marrow plasma and
marrow stromal cell cultures were then methyl trans-
esterified, and the resulting fatty acid methyl esters
w xwere separated by gas chromatography 10 . Stan-
dards were run to identify the compounds quantified
by gas chromatography.
[ 3 ]2.3. Incorporation of H -AA in marrow stromal
cells
 5.Trypsinized cells 1=10 were plated in 6-well
plates in 5 ml of RPMI 1640 with 20% FCS and were
 5grown 5 days. Subconfluent cultures 2 to 3=10
.cells per well were washed three times with HBSS
to eliminate FCS before use. The incorporation of
w3 x  .H -AA Amersham, les Ulis, France was per-
formed with cells in classical monolayer maintained
w3 xin 1 ml of RPMI 1640 medium without FCS. H -AA
 .0.1 mCi; 210 Cirmmol was added into the medium
for 10 min, 1, 5 and 24 h. At the end of the
experiments, supernatants were recovered and acidi-
 .fied to pH 3 citric acid 3 M . Supernatants and
adherent cells were then stored at y208C until used.
In some experiments AA incorporation was investi-
gated with cells grown for 48 h in serum-free medium
before labeling. In other experiments AA incorpora-
tion was made with 20% FCS in the medium.
For AA remodelling studies, cells were labeled
w3 xwith H -AA for 2 h, washed with HBSS, and
incubated in 1 ml of RPMI 1640 without FCS for 2, 5
and 22 h or used immediately. Cells and supernatants
were stored as above.
2.4. Lipid extraction
Acidified supernatants were extracted with diethyl
w xether and ethylacetate 11 . Lipid extracts were evap-
orated, recovered in 150 ml of diethyl ether, applied
 . to a thin layer chromatography TLC plate Silica
 . .gel 60 20=20 cm, 0.25 mm , Merck and submitted
to TLC. The plate was developed in the organic
phase of the mixture: ethyl acetaterisooctaneracetic
 . w xacidrwater 11:5:2:10, vrvrvrv 11 . Adherent
cells were scraped, mixed with 1 ml of 0.1% sodium
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dodecyl sulfate in water, and incubated for 30 min at
 .568C with 3 ml of chloroformrmethanol 2:1, vrv .
The chloroformic extract was washed with 5 ml of
 .0.1 M KClrmethanolrchloroform 96:92:6, vrvrv ,
w xand was evaporated 11 . The dry extract was recov-
ered in 150 ml of chloroform and applied to a TLC
plate. The plate was developed in the mixture of
 .diethyl etherrhexaneracetic acid 70:30:1; vrvrv .
Each lane was divided in areas of 0.5 cm length
which were scraped into vials and radioactivity was
measured on a Packard liquid scintillation counter.
 .Solutions of monoglycerides MG , diglycerides
 .  .  .DG , triglycerides TG , phospholipids PL and AA
were used as standards and visualized with iodine
vapour.
2.5. Analysis of labeled PL
For the separation of the various species of cellular
PL, the corresponding areas were scraped from the
TLC plates and were extracted with chloro-
 .formrmethanol 2:1, vrv . Samples were then
rechromatographed using a solvent system of chloro-
formrmethanolracetic acidrwater 50:30:8:4,
. w xvrvrvrv 11 . Each lane was divided in areas of
0.5 cm length and processed as above. Solutions of
 .  .phosphatidylcholine PC , phosphatidylserine PS ,
 .phosphatidylinositol PI , and phosphati-
 .dylethanolamine PE were used as standards and
visualized with iodine vapour. In this chromatogra-
phy, PI and PS migrated to the same area.
To ensure that the labeled compound in cellular PL
was authentic AA, labeled PL were submitted to base
w xhydrolysis 12 . The labeled PL were resuspended in
 .1 ml of 2 M KOH in ethanolrwater 3:1, vrv . After
40 min at 608C, 1 ml of water and 1 ml of 6 N HCl
were added to the mixture to acidify the phase pH
.3 . Labeled compounds were extracted with chloro-
 .formrmethanol 2:1, vrv and rechromatographed
using a solvent system of diethyl etherrhexaneracetic
 .acid 70,30,1; vrvrv . The amount of radioactivity
migrating with PL and free AA was determined by
liquid scintillation counting.
In another set of experiments labeled PL were
hydrolyzed with PLA from bovine and porcine pan-2
 .creas Sigma . Briefly, labeled PL samples were re-
suspended in 1 ml of diethyl etherrmethanol 95:5,
.  .vrv containing 50 ml of Tris buffer 0.05 M , CaCl2
 .  .25 mM , EDTA 1 mM , and 1 mg of phospholi-
pase. The reaction mixture was incubated at 378C for
2 h with continuous shaking. After evaporation of
solvent, samples were rechromatographed as for base
hydrolysis.
2.6. Production of PGE , 6-Keto-PGF and LTB2 1a 4
by human bone marrow stromal cells
 5.Human bone marrow stromal cells 2=10 in
24-well plates were incubated in 1 ml of RPMI 1640
 .  .with CaCl 2 mM and MgCl 0.5 mM and stimu-2 2
 .  .lated with PMA 1 mM , IL-6 10 ngrml and
 .TNF-a 10 ngrml at 378C for 5, 20, 60 and 180
min. Supernatants were recovered and stored at
y808C until assay. PGE , 6-keto-PGF the stable2 1a
.metabolite of PGI and LTB levels were deter-2 4
mined with enzyme linked immunosorbent assay
 .  .ELISA kits Cayman Chemicals, Ann Harbor, MI .
Results are reported as mean"SEM of three inde-
pendent experiments. Data were compared with
Mann–Whitney U-test. A P-0.05 was considered
significant.
2.7. Cell proliferation
w3 xIt was assessed by H -thymidine incorporation
into DNA and cell counts as previously reported
w x  4 .13,14 . Briefly, cells 1=10 per well were plated
for 24 h in 96-well plates in 100 ml of culture
medium. Adherent cells were washed with HBSS and
200 ml of serum-free medium was added to each well
for 2 days. Adherent cells were reactivated with 100
ml of RPMI 1640 with 5% or 20% FCS. AA Tebu,
.Le Perray-en-Yvelines, France or the appropriate
 .vehicle 10 ml of 2% HSA were added immediately
after reactivation. After 60 h of incubation, cultures
w3 xwere pulsed for 12 h with 1 mCirml H -thymidine
 .Amersham and the cells were harvested using a
Skatron cell harvester. Data are reported as mean
dpm"SEM of sixplicate samples. In separate sets of
 .experiments, cells in triplicate samples were har-
vested after trypsin treatment 0.05% trypsin for 5
.min at 378C and counted by using a haemocytome-
ter. Results were compared with Student’s t-test for
paired samples. A P-0.05 was considered signifi-
cant.
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3. Results
3.1. Fatty acid composition of human bone marrow
plasma and marrow stromal cell cultures
The fatty acid compositions of the human bone
marrow plasma and cultured marrow stromal cells are
shown in Table 1. Enrichment of media with 1 mM
AA significantly P-0.05, Mann–Whitney U-test,
.five experiments increases this fatty acid in total
marrow stromal cell lipids as compared with controls
25.30"5.36% vs. 9.52"0.40% for AA-supple-
.mented and control cells, respectively .
[ 3 ]3.2. Incorporation of H -AA in bone marrow stro-
mal cell lipids
After 10 min, 1, 5 and 24 h of incubation with
w3 xH -AA, human bone marrow stromal cells had in-
corporated 10, 33, 75 and 76% of the initially added
radioactivity, respectively mean of three experi-
.ments . Lipids were extracted from labeled cells and
separated into classes by TLC. The distribution of
label in cell lipids as a function of time is shown in
Fig. 1. A trafficking of labeled AA from TG to PL
was observed. At 24 h, 83% of the label was recov-
ered in PL while 10% was recovered in TG. Less
than 5% of label was recovered in DG or as free AA.
Labeled MG were not detected. The culture of cells
for 48 h in serum-free medium before labeling or the
Table 1
Fatty acid composition of human bone marrow plasma and
human bone marrow stromal cell cultures
Major fatty acids Marrow plasma Marrow stromal cells
 .  .ns4 ns5
C14:0 1.70"0.66 2.21"0.26
C16:0 24.1"0.86 25.25"0.35
C16:1 3.33"0.20 1.96"0.70
C18:0 7.30"0.30 21.11"0.47
C18:1 35.54"2.74 20.06"0.89
C18:2 14.33"2.33 4.10"0.84
C20:4 2.5"0.90 9.52"0.40
aOthers 11.20"0.84 15.80"1.34
 .Data mean"SEM are reported as the percentage of fatty acid
species.
a  .Others: includes the sum of all other fatty acids not shown that
were -1.5% of total fatty acids. C20:4 is arachidonic acid.
w3 xFig. 1. Time-course of H -AA incorporation into human bone
w3 xmarrow stromal cell lipids. Cells were incubated with H -AA
for 10 min, 1, 5, or 24 h. Lipids were extracted and separated as
described in Section 2. Results are expressed as the percentage of
total radioactivity found in cells. Mean"SEM of three indepen-
dent experiments in duplicate. PL: phospholipids; DG: diglyc-
erides; TG: triglycerides; AA: arachidonic acid.
presence of 20% FCS in the medium during labeling
had no effect on the percentages of AA incorporated
 .into PL, DG or TG data not shown .
[ 3 ]3.3. Incorporation of H -AA in bone marrow stro-
mal cell PL species
w3 xWe next investigated the distribution of H -AA
into PL species using cells labeled for 24 h. The
 .percentage mean of three experiments of incorpo-
 .rated AA into PE mean 67%, range 60–71% was
 .greater than for PC mean 18%, range 14–22% and
w3 xFig. 2. Trafficking of H -AA into PL species. Cells were
w3 xlabeled for 2 h with H -AA. Medium was removed and cells
w3 xwere incubated with medium free of H -AA for 2, 5 or 22 h.
Results are expressed as the percentage of total radioactivity
found in PL species. Mean"SEM of three independent experi-
ments in duplicate. PC: phosphatidylcholine; PE: phos-
phatidylethanolamine; PI q PS: phosphatidylinositol q
 .phosphatidyl serine comigration .
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 .  .  .Fig. 3. Production of LTB A , PGE B and 6-keto-PGF C4 2 1a
by human bone marrow stromal cells. Cells were stimulated with
 .  .PMA 1 mM and TNF-a 10 ngrml at 378C for various
periods of time. PGE , 6-keto-PGF and LTB levels were2 1a 4
determined in cell supernatants by ELISA. Mean"SEM of three
independent experiments. ) P -0.05 as compared to controls
 .Mann–Whitney U-test .
 .PIqPS mean 14%, range 13–16% . No difference
w3 xin the distribution of label was found when H -AA
was incorporated with 20% FCS in the culture
medium or using cells grown for 48 h in serum-free
 .medium before labeling data not shown . In a sepa-
rate set of experiments we have investigated the
putative exchange of labeled AA between PL species.
Cells labeled for 2 h were washed and grown in
w3 xculture medium free of H -AA for 2, 5 or 22 h.
Under these experimental conditions no trafficking of
w3 xH -AA was documented between the various PL
 .species Fig. 2 .
Base hydrolysis of labeled PL resulted in the loss
 .of 93% mean of three experiments of radioactivity,
which was recovered as free fatty acid. Similarly
treatment of labeled PL with PLA from porcine2
pancreas or bovine pancreas lead to the loss of 92%
 .and 91% mean of two experiments of label, respec-
tively.
3.4. Production of PGE , 6-Keto-PGF and LTB2 1a 4
by bone marrow stromal cells
 .As reported in Fig. 3, PMA 1 mM and TNF-a
 .  .10 ngrml significantly P-0.05 stimulated PGE2
and LTB production by human bone marrow stro-4
 .mal cells. PMA significantly P-0.05 stimulated
their 6-keto-PGF synthesis. In our experimental1a
 .conditions, IL-6 10 ngrml was not a stimulant of
PGE , 6-keto-PGF and LTB production by hu-2 1a 4
 .man bone marrow stromal cells data not shown .
3.5. Effect of AA on bone marrow stromal cell growth
As reported in Table 2, the addition of AA 1 mM
.  .to 1 nM had no significant P)0.05 effect on the
w3 xH -thymidine incorporation by cells cultured in 5%
or 20% FCS. No significant Ps0.17, Mann–Whit-
.  .ney U-test, four experiments effect of AA 1 mM
was found after 3 days of growth on the number of
Table 2
w3 xEffects of AA on H -thymidine incorporation of human bone marrow stromal cells
FCS Controls 1 mM AA 100 nM AA 10 nM AA 1 nM AA
5% 2567"469 2052"335 2240"407 2202"405 2160"365
20% 3947"644 3988"572 3563"1022 3847"773 4187"1671
 .Cells were grown with 5% or 20% FCS in medium. Data in dpm are the mean"SEM of six independent experiments in sixplicate.
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 3 .viable cells 55.4"8.2=10 cells as compared with
 3 .controls 60.6"5.2=10 cells .
4. Discussion
Studies report the regulatory role of AA metabo-
lites such as PGE and LTB in human bone marrow2 4
w xhematopoiesis 2–5 . Marrow stromal cells act on
human hematopoiesis by secreting cytokines and
growth factors that modulate the growth of bone
w xmarrow progenitors 6 . Marrow stromal cells also
produce the lipidic mediator platelet-activating factor
 . w x w xPAF 7 that enhances their growth 13 . In this
study we have investigated the capacity of bone
marrow stromal cells to capture AA, to produce some
AA metabolites as well as the role of AA in their
growth.
Using gas chromatography analysis, we report the
presence of AA in human bone marrow plasma and
marrow stromal cell cultures. Fatty acid cell composi-
tion is substantially modified by growing these cells
in AA enriched media. Similarly to several other cell
w x w3 xtypes 15–18 , experiments with H -AA indicate
that human bone marrow stromal cells incorporate
AA into PL and TG. Time-course experiments indi-
cate a transfer of AA from TG to PL. In some cell
types the incorporation of AA into TG is considered
to be an important mechanism to capture fatty acids
w xin the culture medium for the biosynthesis of PL 19 .
Base hydrolysis and PLA -treatment experiments2
demonstrate that AA is incorporated unmodified in
PL and is linked by an ester bond. Prelabeling-chase
experiments indicate a preferential incorporation of
AA into PE and no trafficking of labeled AA be-
tween PL species.
While PAF stimulates the proliferation of human
w xbone marrow stromal cells 13 , AA has no effect on
w3 xtheir growth assessed by H -thymidine incorpora-
tion into DNA and cell counts. Similarly, AA
metabolites such as LTB , LTC , lipoxin A , lipoxin4 4 4
B , 12-HETE and 15-HETE have no effect on their4
w xgrowth 20 .
We show, for the first time, that stimulated human
bone marrow stromal cells produce some AA
metabolites that act on the growth of human marrow
w xerythroid and myeloid progenitors 2–5 . Thus, PMA
is a stimulant of PGE , 6-keto-PGF and LTB2 1a 4
production by human bone marrow stromal cells.
TNF-a stimulates their PGE and LTB synthesis. In2 4
contrast, IL-6 has no effect on their PGE , 6-keto-2
PGF and LTB production. In this study PMA,1a 4
IL-6 and TNF-a are used at concentrations that
stimulate cytokine production by human bone mar-
row stromal cells. Thus, PMA stimulates their syn-
thesis of macrophage colony stimulating factor M-
.  .CSF , leukemia inhibitory factor LIF , IL-6 and IL-8
w x8,21–23 . TNF-a stimulates their LIF, IL-6 and IL-8
w xproduction 21,23 while IL-6 stimulates their LIF
w xand IL-8 synthesis 21,23 .
In conclusion human bone marrow stromal cells
readily incorporate AA into their membrane PL and
might participate in the control of marrow AA con-
centrations. PGE and LTB act on the growth of2 4
human marrow hematopoietic progenitors. Stimulated
human bone marrow stromal cells produce PGE and2
LTB highlighting that they might modulate marrow4
hematopoiesis not only by producing cytokines but
also by releasing lipid mediators.
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